1. AB0160 Effects of TOFACITINIB (CP-690, 550) on lipid biomarkers in rat adjuvant-induced arthritis (AIA) model and in patients with active rheumatoid arthritis. (23rd January 2014) Authors: McInnes, I.; Kaplan, I.; Boy, M.; Riese, R.; Zuckerman, A.; Clark, J.; Kishore, N.; Brosnan, M.; Zwillich, S.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0595 Changes in serum creatinine in patients with active rheumatoid arthritis treated with TOFACITINIB (CP-690, 550). (23rd January 2014) Authors: Isaacs, J.; Nduaka, C.; Zuckerman, A.; Krishnaswami, S.; Riese, R.; Lan, S.; Hutmacher, M.; Boy, M.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Connection of organics to atmospheric new particle formation and growth at an urban site of Beijing. (February 2015) Authors: Wang, Z.B.; Hu, M.; Pei, X.Y.; Zhang, R.Y.; Paasonen, P.; Zheng, J.; Yue, D.L.; Wu, Z.J.; Boy, M.; Wiedensohler, A. Journal: Atmospheric environment Issue: Volume 103(2015) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Connection of organics to atmospheric new particle formation and growth at an urban site of Beijing. (February 2015) Authors: Wang, Z.B.; Hu, M.; Pei, X.Y.; Zhang, R.Y.; Paasonen, P.; Zheng, J.; Yue, D.L.; Wu, Z.J.; Boy, M.; Wiedensohler, A. Journal: Atmospheric environment Issue: Volume 103(2015) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0137 Effects of tofacitinib on lipid biomarkers in patients with active rheumatoid arthritis. (23rd January 2014) Authors: McInnes, I. B.; Kaplan, I.; Boy, M.; Riese, R.; Zuckerman, A.; Gruben, D.; Brosnan, M. J.; Zwillich, S.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P727: NK-CELL IMMUNOEDITING BY MESENCHYMAL STROMAL CELLS IN MDS. (23rd June 2022) Authors: Bisio, V.; Schell, B.; Zhao, L.-P.; Lereclus, E.; Boy, M.; Bonaud, A.; Caignard, A.; Toubert, A.; Fenaux, P.; Espéli, M.; Balabanian, K.; Adès, L.; Dulphy, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0136 Cardiovascular safety findings in rheumatoid arthritis patients treated with tofacitinib (CP-690, 550), a novel, oral jak inhibitor. (23rd January 2014) Authors: Charles-Schoeman, C.; Wicker, P.; Sechtem, U.; Gonzalez-Gay, M.A.; Wood, S.; Boy, M.; Geier, J.; Gruben, D.; Soma, K.; Riese, R.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0140 Tofacitinib (CP-690, 550), an oral janus kinase inhibitor: Analysis of gastrointestinal adverse events across the rheumatoid arthritis clinical programme. (23rd January 2014) Authors: Lee, E.B.; Curtis, J.R.; Riese, R.; Connell, C.; Chew, R.; Boy, M.; Maller, E.; Su, C.; Wang, L.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0145 Association of Mean Changes in Laboratory Safety Parameters with C-Reactive Protein at Baseline and Week 12 in Rheumatoid Arthritis Patients Treated with Tofacitinib. (10th June 2014) Authors: Strand, V.; Isaacs, J.; Beal, J.; Nduaka, C.; Krishnaswami, S.; Riese, R.; Boy, M.; Menon, S. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. THU0210 Malignancy Data in Tofacitinib-Treated Japanese Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Tanaka, Y.; Takeuchi, T.; Yamanaka, H.; Sugiyama, N.; Yoshinaga, T.; Togo, K.; Geier, J.; Boy, M.; Connell, C.A. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗